Metagenomi to Present at Upcoming Scientific Meetings

Core Insights - Metagenomi, Inc. is set to present at two significant scientific meetings, showcasing its advancements in gene editing technologies [1][2] - The company utilizes an AI-driven metagenomics platform to develop curative therapeutics, aiming to correct genetic mutations across the genome [3] Presentation Details - At TIDES USA 2025, Metagenomi will deliver an oral presentation titled "AI-Guided Metagenomic Discovery of Compact CRISPR Systems for In Vivo Therapeutic Genome Editing" on May 22, 2025 [2] - The company will also present three posters at the ASGCT 2025 Annual Meeting, focusing on various aspects of in vivo genome editing and CRISPR systems on May 13, 2025 [2] Company Overview - Metagenomi is dedicated to developing precision genetic medicines, leveraging four billion years of microbial evolution to create novel genome editing tools [3] - The company's toolbox includes programmable nucleases, base editors, and advanced integration systems, positioning it to address a wide range of genetic mutations [3]